HTML has links - PDF has Authentication
246-922-405  <<  246-922-410 >>   246-922-415

PDFWAC 246-922-410

Approval of monitoring programs.

The board shall approve the monitoring program to facilitate the recovery of podiatric physicians. The board shall enter into a contract with the monitoring program.
(1) A monitoring program:
(a) May provide either evaluations or treatment, or both to the participating podiatric physicians;
(b) Shall enter into a contract with the podiatric physician and the board to oversee the podiatric physician's compliance with the requirement of the program;
(c) Shall maintain records on participants;
(d) Shall be responsible for providing feedback to the podiatric physician as to whether treatment progress is acceptable;
(e) Shall report to the board any podiatric physician who fails to comply with the requirements of the monitoring program;
(f) Shall provide the board with a statistical report and financial statement on the program, including progress of participants, at least annually, or more frequently as requested by the board;
(g) Shall provide for the board a complete biennial audited financial statement;
(h) Shall enter into a written contract with the board and submit monthly billing statements supported by documentation.
(2) Monitoring program staff must have the qualifications and knowledge of impairing health conditions and the practice of podiatric medicine and surgery as defined in chapter 18.22 RCW to be able to evaluate:
(a) Drug screening laboratories;
(b) Laboratory results;
(c) Providers of treatment for impairing health conditions, both individual and facilities;
(d) Podiatric physician support groups;
(e) Podiatric physicians' work environment; and
(f) The ability of the podiatric physicians to practice with reasonable skill and safety.
(3) The program staff of the monitoring program may evaluate and recommend to the board, on an individual basis, whether a podiatric physician will be prohibited from engaging in the practice of podiatric medicine and surgery for a period of time and restrictions, if any, on the podiatric physician's access to controlled substances in the workplace.
(4) The board shall provide the monitoring program orders and agreements requiring any treatment, monitoring, or limitations on the practice of podiatric medicine and surgery for those participating in the program.
[Statutory Authority: RCW 18.57.005 and 2022 c 43. WSR 24-01-121, § 246-922-410, filed 12/19/23, effective 1/19/24. Statutory Authority: RCW 18.22.015 and chapter 18.22 RCW. WSR 94-14-082, § 246-922-410, filed 7/5/94, effective 8/5/94.]
Site Contents
Selected content listed in alphabetical order under each group